People

  1. Houlihan
    Houlihan
  2. Chowdhury
    Chowdhury
  3. Fleming
    Fleming
  4. Silber
    Silber
  5. Riaz
    Riaz
  6. Chhangawala
    Chhangawala
  7. Avila
    Avila
  8. Rodriguez
    Rodriguez
  9. Casey
    Casey
  10. Demetrio De Souza Franca
    Demetrio De Souza Franca
  11. Schmidt
    Schmidt
  12. Ntiamoah
    Ntiamoah
  13. Marians
    Marians
  14. Menghrajani
    Menghrajani
  15. Wu
    Wu

Recent Works

  1. Patient-centered outcomes in ARIEL3, a phase 3, randomized, placebo-controlled study of rucaparib maintenance treatment in patients with recurrent ovarian carcinoma
    Meeting Abstract

    Bedel, D. J.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; Leary, A.; more...
    Value in Health (2019)

    Fulltext@MSK | Save
  2. Cost-effectiveness of a 24-month fixed duration of venetoclax in combination with rituximab in relapsed or refractory chronic lymphocytic leukemia in the United States
    Meeting Abstract

    Huntington, S. F.; Strunz-McKendry, T.; Masaquel, A. S.; Shapouri, S.; Sail, K.; Durno, N.; Mato, A.
    Value in Health (2019)

    Fulltext@MSK | Save
  3. Quality adjusted time without symptoms of disease progression or toxicity (Q-TWIST) of nivolumab plus ipilimumab (NIVO+IPI) vs sunitinib (SUN) among untreated advanced renal cell carcinoma (ARCC) patients (patients) with intermediate or poor prognostic risk
    Meeting Abstract

    Shah, R.; Botteman, M.; Kwon, Y.; Gooden, K. M.; Cella, D.; Motzer, R.
    Value in Health (2019)

    Fulltext@MSK | Save